KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
KDNY
Delisted
KDNY was delisted on the 10th of August, 2023.
157 hedge funds and large institutions have $1.42B invested in Chinook Therapeutics, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 57 increasing their positions, 49 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
5% less capital invested
Capital invested by funds: $1.49B → $1.42B (-$67.2M)
25% less funds holding in top 10
Funds holding in top 10: 8 → 6 (-2)
Holders
157
Holding in Top 10
6
Calls
$5.61M
Puts
$1M
Top Buyers
| 1 | +$30.4M | |
| 2 | +$24.8M | |
| 3 | +$20.5M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$11.2M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$8.43M |
Top Sellers
| 1 | -$25M | |
| 2 | -$12.4M | |
| 3 | -$9.24M | |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
-$5.66M |
| 5 |
Millennium Management
New York
|
-$4.45M |